Table 3.
Fragmentation efficiency of singly protonated α-MSH analogs and bioconjugates by MALDI MS/MS.
Compound | ISD | LID | CID |
---|---|---|---|
1; (4) | − | + +; (+ + +) | + + +; (+ +) |
2; (5) Dau at N-terminus |
− | + | + |
3; (6) Dau at Lys |
− | + +; (+) | + +; (+) |
Symbols: −: no peptide sequence related fragments; +: the sequence coverage is 10–30%, where the relative intensity of the fragments is ≥5%; + +: the sequence coverage is 31–60%, where the relative intensity of the fragments is ≥5%; + + +: the sequence coverage is ≥61%, where the relative intensity of the fragments is ≥5%. Values for the compounds 4, and 6 are in brackets.